[Functional MRI procedures in the diagnosis of brain tumors: Perfusion- and diffusion-weighted imaging].
Despite the increased diagnostic accuracy of contrast material enhanced MR imaging, specification and grading of brain tumors are still only approximate at best: neither morphology, nor relaxation times or contrast material enhancement reliably predict tumor histology or tumor grade. As histology and tumor grade strongly influence which therapy concept is chosen, a more precise diagnosis is mandatory. With diffusion- and perfusion-weighted MR imaging (DWI, PWI) it is now possible to obtain important information regarding the cellular matrix and the relative regional cerebral blood volume (rrCBV) of brain tumors, which cannot be obtained with standard MR techniques. These dynamic-functional imaging techniques are very useful in the preoperative diagnosis of gliomas, lymphomas, and metastases, as well as in the differentiation of these neoplastic lesions from abscesses, atypical ischemic infarctions, and tumor-like manifestations of demyelinating disease. Additionally, they appear suitable for determining glioma grade and regions of active tumor growth which should be the target of stereotactic biopsy and therapy. After therapy these techniques are helpful to better assess the tumor response to therapy, possible therapy failure and therapy complications such as radiation necrosis.
Hartmann
M
M
Abteilung Neuroradiologie, Neurologische Klinik, Universitätsklinikum Heidelberg, Germany.
Heiland
S
S
Sartor
K
K
D001706:Biopsy; D001812:Blood-Brain Barrier / Q000502:physiology; D001921:Brain / Q000098:blood supply / Q000473:pathology; D001932:Brain Neoplasms / Q000098:blood supply* / Q000175:diagnosis / Q000473:pathology; D004058:Diffusion; D006801:Humans; D007089:Image Enhancement; D008279:Magnetic Resonance Imaging; D009389:Neovascularization, Pathologic / Q000175:diagnosis / Q000473:pathology; D011379:Prognosis; D012039:Regional Blood Flow / Q000502:physiology